Inhibition of glutamate-induced nitric oxide synthase activation by dopamine in cultured rat retinal neurons

Neuroscience Letters

Volumn 347, Issue 3, 2003, Pages 155-158

  Yamauchi, Tomofusa ^a   Kashii, Satoshi ^a   Yasuyoshi, Hiroki ^a   Zhang, Shen ^a   Honda, Yoshihito ^a   Ujihara, Hisamitsu ^a   Akaike, Akinori ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

Calcium; D1 receptor; Dopamine; Excitotoxicity; Glutamate; N methyl D aspartate; Nitric oxide; Retinal cell culture

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; CYCLIC AMP; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE RECEPTOR STIMULATING AGENT; EXCITOTOXIN; GLUTAMIC ACID; IONOMYCIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NITRIC OXIDE SYNTHASE; S NITROSOCYSTEINE; ALPHA AMINO 3 HYDROXY 5 METHYL 4 ISOXAZOLEPROPIONIC ACID; AMINO ACID RECEPTOR STIMULATING AGENT; KAINIC ACID; N METHYLASPARTIC ACID; NEURONAL NITRIC OXIDE SYNTHASE; NOS1 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL PROTECTION; CHEMICAL ANALYSIS; CONTROLLED STUDY; DRUG INHIBITION; ENZYME ACTIVATION; ENZYME ACTIVITY; INHIBITION KINETICS; NERVE CELL CULTURE; NEUROPROTECTION; NONHUMAN; PATCH CLAMP; PRIORITY JOURNAL; RAT; RAT STRAIN; RECEPTOR SENSITIVITY; RETINA NERVE CELL; ANIMAL; CELL CULTURE; CYTOLOGY; DRUG EFFECT; DRUG POTENTIATION; ENZYMOLOGY; METABOLISM; NERVE CELL; PHYSIOLOGY; RETINA; WISTAR RAT;

2,3,4,5-TETRAHYDRO-7,8-DIHYDROXY-1-PHENYL-1H-3-BENZAZEPINE; ALPHA-AMINO-3-HYDROXY-5-METHYL-4-ISOXAZOLEPROPIONIC ACID; ANIMALS; CELLS, CULTURED; DOPAMINE; DOPAMINE AGONISTS; ENZYME ACTIVATION; EXCITATORY AMINO ACID AGONISTS; KAINIC ACID; N-METHYLASPARTATE; NEURONS; NITRIC OXIDE SYNTHASE; NITRIC OXIDE SYNTHASE TYPE I; PATCH-CLAMP TECHNIQUES; RATS; RATS, WISTAR; RECEPTORS, DOPAMINE D1; RECEPTORS, N-METHYL-D-ASPARTATE; RETINA;

EID: 0041589131     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(03)00669-4     Document Type: Article

References (16)

1. Adachi K., Fujita Y., Morizane C., Akaike A., Ueda M., Satoh M., Masai H., Kashii S., Honda Y. Inhibition of NMDA receptors and nitric oxide synthase reduces ischemic injury of the retina. Eur. J. Pharmacol. 350:1998;53-57.
2. Adachi K., Kashii S., Masai H., Ueda M., Morizane C., Kaneda K., Kume T., Akaike A., Honda Y. Mechanism of the pathogenesis of glutamate neurotoxicity in retinal ischemia. Graefes Arch. Clin. Exp. Ophthalmol. 236:1998;766-774.
3. Capeda C., Colwell C.S., Itri J.N., Gruen E., Levine M.S. Dopaminergic modulation of early signs of excitotoxicity in visualized rat neostriatal neurons. Eur. J. Neurosci. 10:1998;3491-3497.
4. Castro N.G., de Mello M.G.F., de Mello F.G., Aracava Y. Direct inhibition of N-methyl-D-aspartate receptor channel by dopamine and (+)-SKF38393. Br. J. Pharmacol. 126:1999;1847-1855.
5. Davis S., Brotchie J., Davies I. Protection of striatal neurons by joint blockade of D1 and D2 receptor in an in vitro model of cerebral hypoxia. Exp. Neurol. 176:2002;229-236.
6. Dawson V.L., Dawson T.M., London E.D., Bredt D.S., Snyder S.H. Nitric oxide mediates glutamate neurotoxicity in primary cortical cultures. Proc. Natl. Acad. Sci. USA. 88:1991;6368-6371.
7. Fenwick E.M., Marty A., Neher E. A patch-clamp study of bovine chromaffin cells and of their sensitivity to acetylcholine. J. Physiol. 331:1982;577-597.
8. Hashimoto N., Matsumoto T., Mabe H., Hashitani T., Nishino H. Dopamine has inhibitory and accelerating effects on ischemia-induced neuronal cell damage in the rat striatum. Brain Res. Bull. 33:1994;281-288.
9. Kashii S., Mandai M., Kikuchi M., Honda Y., Tamura Y., Kaneda K., Akaike A. Dual action of nitric oxide in N-methyl-D-aspartate receptor-mediated neurotoxicity in the cultured retinal neurons. Brain Res. 711:1996;93-101.
10. Kashii S., Takahashi M., Mandai M., Shimizu H., Honda Y., Sasa M., Ujihara H., Tamura Y., Yokota T., Akaike A. Protective action of dopamine against glutamate neurotoxicity in the retina. Invest. Ophthalmol. Vis. Sci. 35:1994;685-695.
11. Kikuchi M., Kashii S., Mandai M., Yasuyoshi H., Honda Y., Kaneda K., Akaike A. Protective effect of FK506 against glutamate-induced neurotoxicity in retinal culture. Invest. Ophthalmol. Vis. Sci. 39:1998;1227-1232.
12. Lee J.M., Zipfel G.J., Choi D.W. The changing landscape of ischaemic brain injury mechanisms. Nature. 399:1999;A7-A14.
13. Melis M.R., Succu S., Argiolas A. Dopamine agonists increase nitric oxide production in the paraventricular nucleus of the hypothalamus: correlation with penile erection and yawning. Eur. J. Neurosci. 8:1996;2056-2063.
14. Morizane C., Adachi K., Furutani I., Fujita Y., Akaike A., Kashii S., Honda Y. N-Nitro-arginine methyl ester protects retinal neurons against N-methyl-D-aspartate-induced neurotoxicity in vivo. Eur. J. Pharmacol. 328:1997;45-49.
15. Morris B.J., Simpson C.S., Mundell S., Maceachern K., Johnston H.M., Nolan A.M. Dynamic changes in NADPH-diaphorase staining reflect activity of nitric oxide synthase: evidence for a dopaminergic regulation of striatal nitric oxide release. Neuropharmacology. 36:1997;1589-1599.
16. 2+ channel blocker, reduces glutamate-induced neurotoxicity and ischemia/reperfusion damage in rat retina. Exp. Eye Res. 70:2000;475-484.